Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

Published:2008-10-15 Issue:20 Volume:14 Page:6674-6682
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Finke James H.,Rini Brian,Ireland Joanna,Rayman Patricia,Richmond Amy,Golshayan Ali,Wood Laura,Elson Paul,Garcia Jorge,Dreicer Robert,Bukowski Ronald

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 428 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for head and neck cancer: Fundamentals and therapeutic development;Auris Nasus Larynx;2024-08

2. Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments;Biochemical Pharmacology;2024-08

3. Cancer Immunotherapy with “Vascular-Immune” Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems;International Journal of Nanomedicine;2024-07

4. Exploiting temporal aspects of cancer immunotherapy;Nature Reviews Cancer;2024-06-17

5. Molecular mechanisms and clinical relevance of endothelial cell cross-talk in clear cell renal cell carcinoma;Upsala Journal of Medical Sciences;2024-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP